COPD is a risk factor for COVID-19, but does not confer increased severity of the disease - 08/12/21

Doi : 10.1016/j.rmed.2021.106640

Jae Seok Jeong ^a,^d,^{^{1
These authors contributed equally to this work.}}, Jong Seung Kim ^b,^c,^d,^{^{1
These authors contributed equally to this work.}}, Yeon Seok You ^b, Sang Woo Yeom ^c, Yong Chul Lee ^a,^d,^⁎
^a Department of Internal Medicine, Research Center for Pulmonary Disorders, Jeonbuk National University Medical School, Jeonju, South Korea
^b Department of Otorhinolaryngology-Head and Neck Surgery, Jeonbuk National University Medical School, Jeonju, South Korea
^c Department of Medical Informatics, Jeonbuk National University, Jeonju, South Korea
^d Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk National University Hospital, Jeonju, South Korea

^∗Corresponding author. Department of Internal Medicine, Jeonbuk National University Medical School, Geonjiro 20, Deokjin-gu, Jeonju, 54907, South Korea.Department of Internal MedicineJeonbuk National University Medical SchoolGeonjiro 20, Deokjin-guJeonju54907South Korea

connectez-vous ou créez un compte

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Abstract

Epidemiologic studies suggest that COPD is associated with an increased risk of poor outcome in patients with COVID-19, although they failed to demonstrate COPD as a risk factor for acquiring COVID-19. However, most data have come from a limited global population. In this nationwide cohort study based on the Korean national health insurance claims-based database, COPD is associated with increased risk for COVID-19 and having COPD does not seem to confer substantial risk for severe COVID-19 and mortality. These findings indicate that heterogeneity in the populations across many countries may complicate the net effects of COPD on the COVID-19-related outcomes.

Le texte complet de cet article est disponible en PDF.

Keywords : COPD, COVID-19, National health insurance service, Severe acute respiratory syndrome coronavirus 2

Plan

Declaration of all sources of funding

CRediT authorship contribution statement

Export

Vol 189

Article 106640- novembre 2021 Retour au numéro

Article précédent

Rationale and design of a mechanistic clinical trial of JAK inhibition to prevent ventilator-induced diaphragm dysfunction
Joseph B. Shrager, Yoyo Wang, Myung Lee, Shannon Nesbit, Winston Trope, Harrison Konsker, Emmanuel Fatodu, Mark S. Berry, George Poulstides, Jeffrey Norton, Thomas Burdon, Leah Backhus, Roger Cooke, Huibin Tang

| Article suivant

High fitness levels offset the increased risk of chronic obstructive pulmonary disease due to low socioeconomic status: A cohort study
Setor K. Kunutsor, Sae Young Jae, Timo H. Mäkikallio, Sudhir Kurl, Jari A. Laukkanen

Bienvenue sur EM-consulte, la référence des professionnels de santé.

connectez-vous ou créez un compte

COPD is a risk factor for COVID-19, but does not confer increased severity of the disease - 08/12/21

Abstract

Plan

Export citations

Fichier

Contenu

Accès rapides

Mon compte

Aide & support

Plateformes Elsevier Masson

Déclaration CNIL